Kelyniam Records Record 3rd Quarter Revenues, 17% Quarter Over Quarter Growth, Reaches Profitability
December 12 2008 - 4:00PM
Marketwired
Kelyniam Global, Inc. (PINKSHEETS: KLYG), an advanced Engineering
and Rapid Prototyping Company specializing in the use of CADCAM
technology, reported record 3rd quarter revenues.
President/CEO Mr. James Ketner stated: "We are growing, and we
have some very exciting new projects in the works. Our second
quarter revenues for 2008 were about $160,000 USD, which is more
than the company had done since inception in 2005 through the end
of first quarter 2008. Our third quarter 2008 revenues were
$188,000, which is a 17% increase in revenues quarter over quarter.
Not spectacular, but gives a pattern of the type of growth rate
management is anticipating over the next 2 years. This type of
growth rate does not include any new acquisitions, or the FDA
approving the process for our cranial implant models."
Financial condition update from Mr. Ketner can be found at:
www.kelyniam.com/investor_relations.htm
Kelyniam's full 3rd quarter report can be found by following the
link: www.kelyniam.com/2008FS/2008Q3.htm
About Kelyniam Global, Incorporated:
Kelyniam Global, Inc. is a balanced vertically-integrated
multi-industry holding corporation. Their divisions and
subsidiaries service a vast array of clients across numerous fields
and industries encompassing, but not limited to, medical,
automotive, aerospace, jewelry, nautical and consumer products. The
company specializes in the use of CADCAM technology with recent
developments in the production of high precision replication of
artificial bone implants for medical applications.
Please visit our website at www.kelyniam.com for our new and
exciting medical technology advancements.
Add to Digg Bookmark with del.icio.us Add to Newsvine
Contact: Michelle LynRay Kelyniam Global, Inc. www.kelyniam.com
1-800-280-8192
Kelyniam Global (PK) (USOTC:KLYG)
Historical Stock Chart
From Sep 2024 to Oct 2024
Kelyniam Global (PK) (USOTC:KLYG)
Historical Stock Chart
From Oct 2023 to Oct 2024